Mitral Valve Prolapse in Pregnancy
Mitral valve prolapse is a benign condition. Mitral regurgitation is only complicated in patients with severe mitral valve prolapse. Women with mitral valve prolapse in the absence of other cardiovascular disorders tolerate pregnancy well and do not develop remarkable cardiac complications. Neverthe...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Sociedade Brasileira de Cirurgia Cardiovascular
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062719/ |
| id |
pubmed-5062719 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-50627192016-10-19 Mitral Valve Prolapse in Pregnancy Yuan, Shi-Min Yan, Song-Li Review Articles Mitral valve prolapse is a benign condition. Mitral regurgitation is only complicated in patients with severe mitral valve prolapse. Women with mitral valve prolapse in the absence of other cardiovascular disorders tolerate pregnancy well and do not develop remarkable cardiac complications. Nevertheless, serious complications of mitral valve prolapse, including arrhythmia, infective endocarditis and cerebral ischemic events, can be present in pregnancy. Debates remain with regard to the use of prophylactic antibiotics and β-blockers in the pregnant women with mitral valve prolapse. The prognosis of the pregnant patients might be closely related to the pathological and (or) functional changes of the mitral valve. Non-myxomatous mitral valve prolapse poses no or little obstetric risks in terms of pregnancy, labor and neonatal complications; whereas myxomatous mitral valve prolapse is a major etiology of valvular heart disease in women of childbearing age. In the pregnant patients with mitral valve prolapse progressing into major complications, surgical interventions are considered. Medicinal treatment of such patients with β-blockers should be a concern for the fetal safety. Sociedade Brasileira de Cirurgia Cardiovascular 2016 /pmc/articles/PMC5062719/ /pubmed/27556316 http://dx.doi.org/10.5935/1678-9741.20160034 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Yuan, Shi-Min Yan, Song-Li |
| spellingShingle |
Yuan, Shi-Min Yan, Song-Li Mitral Valve Prolapse in Pregnancy |
| author_facet |
Yuan, Shi-Min Yan, Song-Li |
| author_sort |
Yuan, Shi-Min |
| title |
Mitral Valve Prolapse in Pregnancy |
| title_short |
Mitral Valve Prolapse in Pregnancy |
| title_full |
Mitral Valve Prolapse in Pregnancy |
| title_fullStr |
Mitral Valve Prolapse in Pregnancy |
| title_full_unstemmed |
Mitral Valve Prolapse in Pregnancy |
| title_sort |
mitral valve prolapse in pregnancy |
| description |
Mitral valve prolapse is a benign condition. Mitral regurgitation is only
complicated in patients with severe mitral valve prolapse. Women with mitral
valve prolapse in the absence of other cardiovascular disorders tolerate
pregnancy well and do not develop remarkable cardiac complications.
Nevertheless, serious complications of mitral valve prolapse, including
arrhythmia, infective endocarditis and cerebral ischemic events, can be present
in pregnancy. Debates remain with regard to the use of prophylactic antibiotics
and β-blockers in the pregnant women with mitral valve prolapse. The
prognosis of the pregnant patients might be closely related to the pathological
and (or) functional changes of the mitral valve. Non-myxomatous mitral valve
prolapse poses no or little obstetric risks in terms of pregnancy, labor and
neonatal complications; whereas myxomatous mitral valve prolapse is a major
etiology of valvular heart disease in women of childbearing age. In the pregnant
patients with mitral valve prolapse progressing into major complications,
surgical interventions are considered. Medicinal treatment of such patients with
β-blockers should be a concern for the fetal safety. |
| publisher |
Sociedade Brasileira de Cirurgia Cardiovascular |
| publishDate |
2016 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062719/ |
| _version_ |
1613682883949494272 |